Peptide Library

A pentadecapeptide derived from human gastric juice. Promotes angiogenesis, upregulates growth factor expression (VEGF, EGF), modulates nitric oxide synthesis, and protects the GI tract. Demonstrated tissue-healing properties across muscle, tendon, ligament, bone, and gut in animal models.

A synthetic fragment of thymosin beta-4, a naturally occurring protein involved in tissue repair. Upregulates actin, promoting cell migration, blood vessel formation, and tissue regeneration. Reduces inflammation and fibrosis.

A synthetic GHRH analog that stimulates the pituitary gland to produce growth hormone in a pulsatile pattern. Often stacked with Ipamorelin for synergistic GH release.

A selective growth hormone secretagogue that stimulates GH release by mimicking ghrelin. Does not significantly increase cortisol, prolactin, or appetite. Considered one of the mildest GH peptides.

A GLP-1 receptor agonist that slows gastric emptying, reduces appetite, improves insulin sensitivity, and promotes satiety. FDA-approved as Ozempic (diabetes) and Wegovy (weight management).

A dual GLP-1 and GIP receptor agonist combining appetite suppression with enhanced metabolic effects. FDA-approved as Mounjaro (diabetes) and Zepbound (weight management).

A naturally occurring copper peptide that stimulates collagen synthesis, promotes wound healing, and has anti-inflammatory and antioxidant properties. Used both topically (skin/hair) and by injection.

A synthetic analog of the first 29 amino acids of GHRH. Stimulates natural GH production in a physiological pulsatile pattern. Previously FDA-approved for pediatric GH deficiency.

An oral growth hormone secretagogue that mimics ghrelin. Increases GH and IGF-1 without affecting cortisol. Notable for oral bioavailability — no injection needed.

A melanocortin receptor agonist that acts centrally in the brain to stimulate sexual desire. Unlike PDE5 inhibitors (Viagra), it works on the nervous system rather than blood flow. FDA-approved as Vyleesi.

A mitochondria-derived peptide that regulates metabolic homeostasis. Activates AMPK, improves insulin sensitivity, enhances fat metabolism. One of the first discovered mitochondrial-derived signaling peptides.

A synthetic tetrapeptide that activates telomerase, potentially elongating telomeres. May regulate melatonin production. Developed by Russian gerontologist Vladimir Khavinson.

A modified fragment of human growth hormone (amino acids 177-191). Stimulates lipolysis and inhibits lipogenesis without GH's growth-promoting or diabetogenic effects.

A synthetic analog of immunomodulatory peptide tuftsin. Anxiolytic and nootropic via GABA, serotonin, and dopamine modulation. Also has immunomodulatory properties. Intranasal administration.

A synthetic ACTH analog with nootropic and neuroprotective effects. Increases BDNF expression, modulates dopamine and serotonin. Developed in Russia for cognitive enhancement and stroke recovery.